Skip to main navigation Skip to search Skip to main content

Menin Inhibition With Revumenib for KMT2A -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)

  • Ghayas C. Issa
  • , Ibrahim Aldoss
  • , Michael J. Thirman
  • , John Dipersio
  • , Martha Arellano
  • , James S. Blachly
  • , Gabriel N. Mannis
  • , Alexander Perl
  • , David S. Dickens
  • , Christine M. Mcmahon
  • , Elie Traer
  • , C. Michel Zwaan
  • , Carolyn S. Grove
  • , Richard Stone
  • , Paul J. Shami
  • , Ioannis Mantzaris
  • , Matthew Greenwood
  • , Neerav Shukla
  • , Branko Cuglievan
  • , Tibor Kovacsovics
  • Yu Gu, Rebecca G. Bagley, Kate Madigan, Yakov Chudnovsky, Huy Van Nguyen, Nicole Mcneer, Eytan M. Stein

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Menin Inhibition With Revumenib for KMT2A -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Keyphrases